The Scleroderma Research Foundation (SRF) has announced the star-studded lineup for its annual Cool Comedy, Hot Cuisine fundraising…
Articles by Andrea Lobo, PhD
Patients with systemic sclerosis (SSc) who have a stem cell transplant see normalized gene activity related to immune function…
CONQUEST, a platform clinical trial launched by the Scleroderma Research Foundation (SRF), is now enrolling people with interstitial lung…
Having scleroderma increases the risk of developing diseases affecting blood vessels of the brain or heart, known as cerebrovascular…
The U.S. Food and Drug Administration (FDA) has granted orphan drug status to BLR-200, a medication that BLR Bio…
People with scleroderma who feel more socially isolated are more likely to report being dissatisfied with life, but this…
Certa Therapeutics’ FT011, an investigational oral therapy for systemic sclerosis (SSc), has been granted fast track designation by the…
AM1476, AnaMar’s investigational anti-fibrotic medication, has been granted orphan drug status by the U.S. Food and…
SARS-CoV-2, the virus that causes COVID-19, may accelerate the development and progression of systemic sclerosis (SSc)…
Hospitalized patients with COVID-19 are more likely to have worse outcomes if they also have systemic sclerosis (SSc), a…